3/27
Coronavirus Research
Existing drugs like statins may be promising COVID-19 treatments
Commentary by two Penn researchers outline a systematic framework for repurposing existing drugs to quickly find new therapies, after an observational study suggested statins may be helpful in combating COVID-19.
COVID-101: Medical students get a crash course in coronavirus
When physicians-in-training at the Perelman School of Medicine were sent home for remote work and virtual learning due to the pandemic, 80 fourth-year students immersed themselves in a crash course on COVID-19 virology, epidemiology, therapies, vaccines, and related topics.
Iranian, American health experts share coronavirus experiences in rare talk
The coronavirus crisis and the move to online events presented Penn’s Middle East Center with a rare opportunity to foster the first public conversation about the virus between senior health officials in Iran and counterparts in the United States.
Uncovering the neurological connections to COVID-19
A variety of research efforts across Penn are working to uncover the neurological implications of COVID-19, including stroke, neuroinflammation, and loss of smell.
Wharton economist talks ensuing coronavirus stimulus bill
Richard Prisinzano of the Penn Wharton Budget Model discusses the competing bills being debated in Congress while extended unemployment benefits stand in limbo.
Interning virtually
The Translational Research Internship Program, offered by the Perelman School of Medicine’s Institute for Translational Medicine and Therapeutics Education Programs, provides mentorship for undergraduates as they complete a translational research project.
New website aids workers unemployed due to COVID-19
Current and former Wharton students created a free job-hunting website for the millions of Americans who have been laid off because of the coronavirus.
Partisanship and the pandemic
Partisanship, not health concerns, is the main driver of whether Americans are social distancing during the coronavirus pandemic, according to a new study.
Researchers find three distinct immune responses for sicker COVID-19 patients
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Navigating cytokine storms
Pairing their expertise, Nilam Mangalmurti of the Perelman School of Medicine and Christopher Hunter of the School of Veterinary Medicine have been working to understand the protective and harmful aspects of the immune response, including in COVID-19.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →